Second swine flu vaccine given green light for October start

Baxter's swine flu vaccine has been given the green light for approval by the European Medicines Agency (EMEA).

The EMEA has granted a 'positive opinion' for Baxter's Celvapan H1N1 pandemic vaccine. It will now need to be granted final marketing authorisation by the European Commission before being made available.

The UK government has contracts to buy swine flu vaccine from GSK and Baxter. GSK's vaccine Pandemrix was granted a 'positive opinion' last month.

England's chief medical officer Sir Liam Donaldson said this week that the vaccination programme would start in the second half of October 'if everything goes to plan'.


Tom Moberly recommends

Swine Flu resource centre

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in